Treating the body, balancing the mind

Precision medicine

Science-based care for trauma, anxiety, and and depression.

What you feel is personal. What we treat is universal.

Backed by clinical evidence, our treatments target the following symptoms

head icon

Disrupted Sleep &
Nightmares

head icon

Hyperarousal

head and cloud icon

Depression

head icon

Anxiety & Panic attacks

hands icon

Social Withdrawal

decoration icon

Isolation & Avoidance

head icon

Irritability

head icon

Difficulties Concentrating

Our treatments

Treating the biological and physiological sources of mental health challenges.

SGB advanced
protocol (DSR)

Two 15-minute treatments that can calm, and reset, the fight or flight system to reduce symptoms associated with anxiety and PTSD

Ketamine

A safe, evidence-based IV therapy delivering low-dose ketamine. It can provide rapid relief from depression, anxiety, and suicidality, with lasting benefits when combined with ongoing care.

Psychiatric care

Integration of the latest medical and psychiatric science, drawing on advances in neurobiology, psychopharmacology, and evidence-based therapeutic approaches to ensure comprehensive and scientifically grounded care.

Take the first step toward feeling better.
Leave your details and we’ll guide you to the treatment that fits you best.

In alliance with Medica Hospital Centers, with our primary location at Raphael Hospital.

In alliance with Medica Hospital Centers, with our primary location at Raphael Hospital.

Proven Care. Measurable Outcomes.

0 +

Treatments already completed in Israel

~ 0 %

of SGB patients report
significant relief from their
PTSD symptoms

HR

0

Clinical studies show that 50%–70% of patients receiving ketamine infusion experience significant relief from depressive symptoms within 24 hours of their first treatment

Approved by

לוגו משרד הבריאות בישראל

Anxiety, depression and PTSD Quiz

Mental Health Quiz 

Dr. Jason Cohen

Chief Medical Officer

Dr. Stuart Seidman

Senior Psychiatrist

Anxiety, depression and PTSD Quiz

Mental Health Quiz 

Created by experts, Stella’s mental health quiz incorporates sampled items from validated psychiatric measures such as the PCL (PTSD), GAD-7 (anxiety), and PHQ-9 (depression), offering an initial, evidence-based signal regarding your potential suitability for Stella’s treatment modalities.

Patient Testimonials

Some may experience instant relief, while others may see gradual progress or require additional treatments. It is essential to recognize that each patient’s unique journey is valid, and our team is dedicated to providing support throughout the entire treatment process. 

man

“Stella gave me the ability to look ahead to fuller lives. I truly believe that this can help anyone like me”

woman

“After surviving a terror attack, Tal shares about the treatment that changed her life.”

woman

“I didn’t believe I would be able to get any relief from something as simple as a shot”

Frequently asked questions about treatment

If you didn’t find an answer to your question, or if you would like to speak to our team confidentially and for free, leave your details at the bottom of the page.

Filter by category

question checkbox filter

Low-dose Ketamine Infusion (Sub-anesthetic dose) is a medical breakthrough primarily intended for people suffering from clinical depression or treatment-resistant depression (depression that has not responded to at least two types of antidepressant medications). Unlike traditional medications that affect serotonin levels, Ketamine acts on the glutamate system in the brain, allowing for a faster and more significant effect.

Yes. Ketamine acts on the NMDA and glutamate system in the brain, a completely different mechanism from most common medications (like Cipralex or Lustral). Therefore, it can also help those who are under medication treatment and still suffer from the symptoms mentioned above. The treatment helps “open a window of opportunity” where the brain becomes more flexible for change.
One of Ketamine’s greatest advantages is its speed. While antidepressant medications (like SSRIs) require weeks to take effect, many patients report initial relief after the first or second treatment. To achieve long-term results, a series of several treatments at regular intervals is usually recommended.
Ketamine helps restore synaptic connections in the brain (a process called neuroplasticity) that have been damaged as a result of depression or trauma. It acts as a “Reset” for the nervous system, and in many cases brings about rapid relief of symptoms, sometimes within hours or a few days, including a significant reduction in suicidal thoughts.
The treatment is especially suitable if you identify with the following symptoms: A feeling of “emptiness” or loss of pleasure (anhedonia): You feel a complete lack of interest in things that once brought you joy. Life seems “grey,” and there is difficulty feeling any emotion – positive or negative. Mental stickiness (rumination): Your brain is in an endless loop of negative thoughts, self-blame, or painful memories, and you feel like you don’t have an “off switch” for this mental noise. Extreme lack of energy (“emotional paralysis”): Simple actions like getting out of bed, showering, or answering the phone seem like impossible tasks. You feel physical and mental heaviness that prevents you from functioning. A deep sense of despair: The thought that the situation will never change, or a feeling of “I’ve tried everything and nothing helped.” Ketamine works on different brain mechanisms and can generate new hope even when everything seems lost. “Brain fog” and concentration difficulties: You feel your thinking is slow, you find it hard to make simple decisions, or you can’t concentrate on anything for more than a few minutes. Difficult thoughts of worthlessness: The feeling that the world would be a better place without you or recurrent thoughts of death as a way to stop the mental suffering.
According to a large scientific review and meta analysis published in 2023, racemic ketamine, which is most commonly administered via intravenous infusion, was found to be more effective and to have more durable effects than esketamine, which is administered as a nasal spray, in the treatment of depression. The main difference is that racemic ketamine produces stronger clinical effects starting from the first dose, is more successful in maintaining mood improvement across repeated treatment sessions, and most importantly, the therapeutic benefits are sustained for several weeks after treatment completion. In contrast, the effects of esketamine tend to diminish more rapidly. Despite the advantage in efficacy observed with racemic ketamine, research indicates that both formulations are considered similarly safe and well tolerated by patients, with appropriate dosing being a key factor for successful treatment in both approaches.
The side effects result directly from the presence of the anesthetic in the area, and therefore they disappear as soon as the anesthetic leaves the system. After the treatment, patients may temporarily/partially experience various symptoms on the side of the injection, such as: red eye, warmth in the face and arms, blocked nose, hoarse voice and difficulty swallowing, dizziness, and headache. The symptoms are expected to pass within 24 hours and usually disappear after 6-8 hours.

When social anxiety or performance anxiety are accompanied by acute physical reactions (such as trembling, stuttering, or sweating), SGB can help moderate the physical response. When the body remains calm, the patient’s self-confidence increases, and they succeed in coping with the threatening situations more effectively.

Many patients report a decrease in the need for tranquilizers after the treatment, but any change in medication must be done in consultation with the treating physician. SGB does not necessarily replace pharmacological or psychological treatment, but rather serves as a “Booster” that allows the patient to be emotionally available for talk therapy and normal daily functioning.
The treatment is also intended for people diagnosed with an anxiety disorder because it focuses on the physiological changes in the “fight or flight” system, which causes symptoms such as sleep difficulties, anxiety attacks, and increased physiological arousal in both anxiety disorders and trauma-related disorders. SGB treatment is not recognized as a treatment for psychotic disorders (such as schizophrenia), personality disorders, or bipolar disorder.

More Resources

Frequently asked questions about treatment

If you didn’t find an answer to your question, or if you would like to speak to our team confidentially and for free, leave your details at the bottom of the page.

Filter by category

question checkbox filter

Low-dose Ketamine Infusion (Sub-anesthetic dose) is a medical breakthrough primarily intended for people suffering from clinical depression or treatment-resistant depression (depression that has not responded to at least two types of antidepressant medications). Unlike traditional medications that affect serotonin levels, Ketamine acts on the glutamate system in the brain, allowing for a faster and more significant effect.

Yes. Ketamine acts on the NMDA and glutamate system in the brain, a completely different mechanism from most common medications (like Cipralex or Lustral). Therefore, it can also help those who are under medication treatment and still suffer from the symptoms mentioned above. The treatment helps “open a window of opportunity” where the brain becomes more flexible for change.
One of Ketamine’s greatest advantages is its speed. While antidepressant medications (like SSRIs) require weeks to take effect, many patients report initial relief after the first or second treatment. To achieve long-term results, a series of several treatments at regular intervals is usually recommended.
Ketamine helps restore synaptic connections in the brain (a process called neuroplasticity) that have been damaged as a result of depression or trauma. It acts as a “Reset” for the nervous system, and in many cases brings about rapid relief of symptoms, sometimes within hours or a few days, including a significant reduction in suicidal thoughts.
The treatment is especially suitable if you identify with the following symptoms: A feeling of “emptiness” or loss of pleasure (anhedonia): You feel a complete lack of interest in things that once brought you joy. Life seems “grey,” and there is difficulty feeling any emotion – positive or negative. Mental stickiness (rumination): Your brain is in an endless loop of negative thoughts, self-blame, or painful memories, and you feel like you don’t have an “off switch” for this mental noise. Extreme lack of energy (“emotional paralysis”): Simple actions like getting out of bed, showering, or answering the phone seem like impossible tasks. You feel physical and mental heaviness that prevents you from functioning. A deep sense of despair: The thought that the situation will never change, or a feeling of “I’ve tried everything and nothing helped.” Ketamine works on different brain mechanisms and can generate new hope even when everything seems lost. “Brain fog” and concentration difficulties: You feel your thinking is slow, you find it hard to make simple decisions, or you can’t concentrate on anything for more than a few minutes. Difficult thoughts of worthlessness: The feeling that the world would be a better place without you or recurrent thoughts of death as a way to stop the mental suffering.
According to a large scientific review and meta analysis published in 2023, racemic ketamine, which is most commonly administered via intravenous infusion, was found to be more effective and to have more durable effects than esketamine, which is administered as a nasal spray, in the treatment of depression. The main difference is that racemic ketamine produces stronger clinical effects starting from the first dose, is more successful in maintaining mood improvement across repeated treatment sessions, and most importantly, the therapeutic benefits are sustained for several weeks after treatment completion. In contrast, the effects of esketamine tend to diminish more rapidly. Despite the advantage in efficacy observed with racemic ketamine, research indicates that both formulations are considered similarly safe and well tolerated by patients, with appropriate dosing being a key factor for successful treatment in both approaches.
The side effects result directly from the presence of the anesthetic in the area, and therefore they disappear as soon as the anesthetic leaves the system. After the treatment, patients may temporarily/partially experience various symptoms on the side of the injection, such as: red eye, warmth in the face and arms, blocked nose, hoarse voice and difficulty swallowing, dizziness, and headache. The symptoms are expected to pass within 24 hours and usually disappear after 6-8 hours.

When social anxiety or performance anxiety are accompanied by acute physical reactions (such as trembling, stuttering, or sweating), SGB can help moderate the physical response. When the body remains calm, the patient’s self-confidence increases, and they succeed in coping with the threatening situations more effectively.

Many patients report a decrease in the need for tranquilizers after the treatment, but any change in medication must be done in consultation with the treating physician. SGB does not necessarily replace pharmacological or psychological treatment, but rather serves as a “Booster” that allows the patient to be emotionally available for talk therapy and normal daily functioning.
The treatment is also intended for people diagnosed with an anxiety disorder because it focuses on the physiological changes in the “fight or flight” system, which causes symptoms such as sleep difficulties, anxiety attacks, and increased physiological arousal in both anxiety disorders and trauma-related disorders. SGB treatment is not recognized as a treatment for psychotic disorders (such as schizophrenia), personality disorders, or bipolar disorder.